Andaç Salman

949 total citations
56 papers, 423 citations indexed

About

Andaç Salman is a scholar working on Rheumatology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Andaç Salman has authored 56 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 22 papers in Dermatology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Andaç Salman's work include Urticaria and Related Conditions (22 papers), Autoimmune Bullous Skin Diseases (15 papers) and Dermatology and Skin Diseases (11 papers). Andaç Salman is often cited by papers focused on Urticaria and Related Conditions (22 papers), Autoimmune Bullous Skin Diseases (15 papers) and Dermatology and Skin Diseases (11 papers). Andaç Salman collaborates with scholars based in Türkiye, Spain and United States. Andaç Salman's co-authors include Tülin Ergun, Emel Kurt, Zeynep Demirçay, Ana M. Giménez‐Arnau, Volkan Topçuoğlu, Neşe Perdahlı Fiş, Burak Tekin, Nural Bekiroğlu, Deniz Yücelten and Nahide Onsun and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Drugs.

In The Last Decade

Andaç Salman

44 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andaç Salman Türkiye 12 192 133 126 75 57 56 423
Vahide Lajevardi Iran 12 201 1.0× 191 1.4× 118 0.9× 138 1.8× 27 0.5× 29 498
Narumol Silpa‐archa Thailand 15 208 1.1× 198 1.5× 105 0.8× 55 0.7× 87 1.5× 46 461
Maryam Ghiasi Iran 15 273 1.4× 151 1.1× 170 1.3× 216 2.9× 140 2.5× 67 691
Yonit Wohl Israel 13 157 0.8× 40 0.3× 113 0.9× 153 2.0× 20 0.4× 32 377
I‐Hsin Huang Taiwan 9 196 1.0× 94 0.7× 102 0.8× 113 1.5× 10 0.2× 25 394
Jarosław Bogaczewicz Poland 12 215 1.1× 117 0.9× 183 1.5× 218 2.9× 10 0.2× 49 573
Sevgi Bahadır Türkiye 10 140 0.7× 127 1.0× 48 0.4× 49 0.7× 77 1.4× 36 363
Rajiv I. Nijhawan United States 11 198 1.0× 114 0.9× 51 0.4× 29 0.4× 21 0.4× 57 451
Sahil Sekhon United States 12 383 2.0× 199 1.5× 74 0.6× 50 0.7× 12 0.2× 24 546
Bruno de Oliveira Rocha Brazil 8 144 0.8× 294 2.2× 78 0.6× 66 0.9× 37 0.6× 16 428

Countries citing papers authored by Andaç Salman

Since Specialization
Citations

This map shows the geographic impact of Andaç Salman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andaç Salman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andaç Salman more than expected).

Fields of papers citing papers by Andaç Salman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andaç Salman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andaç Salman. The network helps show where Andaç Salman may publish in the future.

Co-authorship network of co-authors of Andaç Salman

This figure shows the co-authorship network connecting the top 25 collaborators of Andaç Salman. A scholar is included among the top collaborators of Andaç Salman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andaç Salman. Andaç Salman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Yi‐Kui, et al.. (2025). Biomarkers in Chronic Spontaneous Urticaria: Are We Ready for its Use in Clinical Practice?. Current Treatment Options in Allergy. 12(1). 1 indexed citations
2.
Salman, Andaç, et al.. (2024). A review of comorbidities in atopic dermatitis. 3. 87–92. 1 indexed citations
3.
Giménez‐Arnau, Ana M. & Andaç Salman. (2024). Urticaria Beyond Omalizumab: What is Next?. Current Treatment Options in Allergy. 11(3). 159–166. 1 indexed citations
4.
Xiang, Yi‐Kui, Murat Türk, Iván Chérrez-Ojeda, et al.. (2024). Psychological Stress and Urticaria: Pathophysiologic and Therapeutic Updates. Current Treatment Options in Allergy. 11(4). 194–210. 4 indexed citations
5.
Salman, Andaç, et al.. (2023). Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences. Current Treatment Options in Allergy. 10(2). 130–147. 3 indexed citations
6.
Salman, Andaç, et al.. (2021). Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real‐life data. Australasian Journal of Dermatology. 62(3). 398–402. 7 indexed citations
7.
Salman, Andaç, et al.. (2021). Real‐life effectiveness and safety of dupilumab in adult patients withmoderate‐to‐severeatopic dermatitis. Dermatologic Therapy. 35(1). e15192–e15192. 4 indexed citations
8.
Kardeş, Sinan, et al.. (2021). Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID‐19 pandemic: Insights from Google Trends. Dermatologic Therapy. 34(2). e14895–e14895. 14 indexed citations
9.
Giménez‐Arnau, Ana M. & Andaç Salman. (2020). Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress. Drugs. 80(16). 1617–1634. 15 indexed citations
10.
Salman, Andaç, et al.. (2020). Netherton syndrome: Temporary response to dupilumab. Pediatric Dermatology. 37(6). 1210–1211. 22 indexed citations
11.
Salman, Andaç, Tülin Ergun, & Ana M. Giménez‐Arnau. (2019). Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study. Journal of Dermatological Treatment. 31(2). 204–209. 10 indexed citations
12.
Salman, Andaç, et al.. (2019). The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria. Journal of Cutaneous Medicine and Surgery. 23(5). 496–500. 15 indexed citations
13.
Salman, Andaç, et al.. (2019). The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real‐life data. Dermatologic Therapy. 32(4). e12975–e12975. 22 indexed citations
14.
Salman, Andaç, et al.. (2019). Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test. Pediatric Dermatology. 36(4). 514–516. 13 indexed citations
15.
Salman, Andaç, et al.. (2019). “Slime”: A trending cause of isothiazolinone contact allergy in children. Contact Dermatitis. 80(6). 409–411. 11 indexed citations
16.
Salman, Andaç, et al.. (2018). Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region. Journal of Cutaneous Medicine and Surgery. 23(3). 258–264. 2 indexed citations
17.
Salman, Andaç, et al.. (2018). Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study. Anais Brasileiros de Dermatologia. 93(6). 819–823. 45 indexed citations
18.
Salman, Andaç, et al.. (2018). Mesalazine‐induced bullous fixed drug eruption. Contact Dermatitis. 79(1). 34–35. 4 indexed citations
19.
Salman, Andaç, et al.. (2017). Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream. Pediatric Dermatology. 34(6). e302–e304. 2 indexed citations
20.
Salman, Andaç, Tülin Ergun, Haner Di̇reskeneli̇, et al.. (2015). Atypical presentations of eosinophilic fasciitis. Indian Journal of Dermatology Venereology and Leprology. 82(1). 47–47. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vahide Lajevardi Breakdown of academic impact, for papers by Narumol Silpa‐archa Breakdown of academic impact, for papers by Maryam Ghiasi Breakdown of academic impact, for papers by Yonit Wohl Breakdown of academic impact, for papers by I‐Hsin Huang Breakdown of academic impact, for papers by Jarosław Bogaczewicz Breakdown of academic impact, for papers by Sevgi Bahadır Breakdown of academic impact, for papers by Rajiv I. Nijhawan Breakdown of academic impact, for papers by Sahil Sekhon Breakdown of academic impact, for papers by Bruno de Oliveira Rocha
Rankless by CCL
2026